Company intelligence / Profile preview

NWT Artemis

Mumbai, Maharashtra, Indiahelloib.com ↗

Ownership: Private
Development stage: Other

Overview

Artemis Biotech manufactures and supplies active pharmaceutical ingredients such as simvastatin, lovastatin, propofol, ethambutol, and artemether. The company operates primarily in India with manufacturing capabilities focused on small molecules used in cardiovascular disease management, infectious diseases like tuberculosis and malaria, and anesthesia. There are no public disclosures of novel drug development or clinical trial results.

Therapeutic areas: OtherCardiovascularInfectious Diseases
Modalities: Small moleculeArtemisinin derivative
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on NWT Artemis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NWT Artemis.

Explore the full profile